| December 7, 2012 | ISSUE NUMBER 279 VOL 8 |
Confirm your PharmExec Direct e-newsletter subscription
We noticed you haven’t opened your PharmExec Direct e-newsletter in quite a while. While we don’t want to lose you as a valuable reader, we understand that preferences do change. If you would like to continue receiving the PharmExec Direct e-newsletter, please take a moment to confirm your subscription by clicking here.
If you have just been having trouble receiving your PharmExec Direct e-newsletter, be sure to add our new email address pharmexec@advanstarpharmex.com to your address book or safe sender list to ensure delivery.
Kind regards,
Pharmaceutical Executive Staff |
Regulatory
US v. Caronia: What Constitutes 'Truthful' Speech?
If a drug's label is not the final word on what is true or untrue about a product, then who decides what can and cannot be said during a sales detail? ...Read more
"Pharmaceutical sales organizations navigate several challenges in today's dynamic markets: volatile sales portfolios, changing managed care contracts, and impaired physician access. Learn 4 key reasons why you need a dynamic alignment management system for today's marketplace.  Download today! |
Special Report
What Key Opinion Leaders Really Want from Pharma
Increased scrutiny and new regulations have seen pharma's relationship with key opinion leaders (KOLs) undergo a paradigm shift in recent years. Sales and marketing teams are no longer the preferred point of contact ...Read More
Global Launch in a Post-Blockbuster Era
What Life Science Companies Need to Know
Read insights, strategies and best practices from Advanstar's award-winning Pharmaceutical Executive magazine and IMS Health designed especially for industry executives, brand teams, and product managers to help them successfully launch their brands in a new and highly competitive global post-blockbuster era.  Click Here |
Global
Pharma's Reputation Improving But Not in China!
The pharmaceutical industry's global reputation is on the mend, even if some countries notably China are more hostile, according to the latest Ipsos Reputation Snapshot for the Pharmaceutical Sector
...Read more
Social Media
Companies Trim Social Media Spending, Change Priorities
A new survey reveals that while more pharma companies are using social media and mobile platforms to enhance their sales and marketing initiatives, budgets did not reflect an increase in social media spend
...Read more
Payer/Pharma Collaboration: A "Real World" Research Strategy for Aligning R&D to Evidence-based Healthcare
Live Webcast: Thursday, December 13, 2012 at 2:00 pm EST
Register Free at  http://www.pharmexec.com/aligning |
Drug Launch
Why Do So Many New Drugs End Up as Launch Failures?
Pharm Exec's new iPad edition eBook, Global Launch in a Post-blockbuster Era, is available for download now
...Read more |
|
|
 // AmerisourceBergen Corporation (Valley Forge, PA) announced that Peyton R. Howell has been named Senior Vice President, AmerisourceBergen Corporation, and President, Global Sourcing and Manufacturer Relations, effective immediately. // Pfenex Inc. (San Diego, CA) announced that Kristi Sarno has joined the company as a Director of Business Development. // Tris Pharma (Monmouth Junction, NJ) appointed Jonathan Berlent as Vice President of Business Development.// BBK Worldwide (Newton, MA) recruited Rebecca Panzer and Lindsay Court to its Client Services Department.
|
|
|
|
|
|
|
 |
|
 |
|
 |
|
 |
|
 |
Compared with 2011, has your company attended more or fewer conferences in 2012?
|
|
|
|
